House of Representatives passes 2 pieces of legislation to boost funding in scientific research; Juul agrees to pay $40 million settlement to North Carolina for its role in the teen vaping epidemic; LA County Department of Public Health recommends for all residents to wear masks in public indoor places amid Delta variant concerns.
Yesterday, the House of Representatives passed 2 pieces of legislation that will increase funding for the National Science Foundation and establish a new directorate for science and engineering, which will expand research opportunities and authorize research funding for the Department of Energy’s Office of Science. In an effort to make the United States more competitive with China, The Hill reports that the National Science Foundation and the Department of Energy’s Office of Science will receive an increased funding boost of about 7% annually. Moreover, Republicans added a provision in committee to ban grant applications from participating in talent programs associated with foreign governments of concern, such as the Thousand Talents program associated with the Chinese government.
Electronic cigarette corporation Juul Labs Inc announced yesterday that it agreed to pay a settlement of $40 million to the state of North Carolina for its role in fueling the teen vaping epidemic. As reported by the Associated Press, Juul will also take more action to prevent underage use and sales, which it had been accused of promoting through ad campaigns that targeted young people for its vaping products that contain addictive nicotine. Juul agreed to not advertise to anyone under the age of 21 in North Carolina and will limit sales amounts of its products online to any state residents.
As reported by the Los Angeles Times, the Los Angeles County Department of Public Health announced recommendations for all residents to wear masks in public indoor places, regardless of vaccination status, amid rising cases of the novel Delta COVID-19 variant. Health officials said that while vaccines have been shown to provide effective protection, there is significant concern regarding those who have yet to be fully vaccinated, as the strain is twice as transmissible as the conventional coronavirus strains.
Mitigating Barriers to Cell and Gene Therapy Access
February 14th 2025Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, according to a white paper from the National Pharmaceutical Council.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More